The animal-health company updated the label for Librela to include side effects such as seizures and paralysis.
Introducing Journavx: the FDA-approved non-opioid, non-addictive drug for acute pain. A major breakthrough in pain medication ...
The U.S. Food and Drug Administration (FDA) approved Journavx (suzetrigine) oral tablets on Thursday as a first-in-class ...
The drug offers a non-addictive alternative to opioids, marking 'an important public health milestone in acute pain ...
A new opioid-free pain medication was approved by the FDA on Thursday, marking a non-addictive alternative for patients.